Guidance

Get medicines to NHS patients earlier via the MHRA-NICE aligned pathway

By streamlining decision-making, the MHRA–NICE aligned pathway will help patients access new medicines 3–6 months sooner.

From:
Medicines and Healthcare products Regulatory Agency
Published
1 April 2026
Last updated
9 April 2026 — See all updates

Documents

Get medicines to NHS patients earlier via the MHRA-NICE aligned pathway

HTML

Details

This will be achieved as the National Institute for Health and Care Excellence’s (NICE) decisions are brought forward to align with the Medicines and Healthcare products Regulatory Agency (MHRA), resulting in the delivery of regulatory and health technology assessment decisions at the same time.

Updates to this page

Published 1 April 2026
Last updated 9 April 2026 href="#full-history">+ show all updates

  1. Added video of webinar on the launch of the MHRA-NICE Aligned Pathway and Integrated Scientific Advice services

  2. First published.

Sign up for emails or print this page